Rheumatoid Arthritis, Anti–Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|9|2311-2322

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.9, 2015-09, pp. : 2311-2322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic value of the anti‐Sa antibody compared with the anti‐cyclic citrullinated peptide antibody in rheumatoid arthritis

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 46-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA-DRB1 and Anti-Cyclic Citrullinated Peptide Antibody Production in Rheumatoid Arthritis

By  

International Archives of Allergy and Immunology, Vol. 137, Iss. 4, 2005-08 ,pp. : 315-318

Karger

Access to resources Recommend Favorite

Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1449-1455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Anti–Citrullinated Protein Antibody Positivity Correlates With Cartilage Damage and Proteoglycan Levels in Patients With Rheumatoid Arthritis in the Hand Joints

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3283-3288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positive association between serum thymic stromal lymphopoietin and anti‐citrullinated peptide antibodies in patients with rheumatoid arthritis

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 239-243

John Wiley & Sons Inc

Access to resources Recommend Favorite